This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Cummings, S. W. Articles by Prough, R. A. Search for Related Content PubMed PubMed Citation Articles by Cummings, S. W. Articles by Prough, R. A.

Metabolism of 3-tert-Butyl-4-hydroxyanisole by Microsomal Fractions and Isolated Rat Hepatocytes

Department of Biochemistry, The University of Texas Health Science Center at Dallas, Dallas 75235 [S. W. C., L. S. C., R. A. P.]; Department of Human Biological Chemistry and Genetics, The University of Texas Medical Branch, Galveston, Texas 77550 [G. A. S. A.]; and Department of Biochemistry and Center for Environmental Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 [F. P. G.]

3-tert-Butyl-4-hydroxyanisole is oxidatively metabolized in the presence of rat liver microsomes, reduced nicotinamide adenine dinucleotide phosphate, and oxygen to yield tert-butylhydroquinone, tert-butylquinone, and a polar metabolite(s). In the presence of human and rat liver microsomes or eight purified cytochrome P-450 isozymes reconstituted with NADPH-cytochrome P-450 reductase, this phenolic antioxidant is converted to the oxidoreduction-active metabolite, tert-butylquinone, that can stimulate the NADPH oxidase activities of these preparations by 2- to 7-fold. The rate of formation of each of the metabolites of 3-tert-butyl-4-hydroxyanisole was increased by pretreatment of rats with either 5,6-benzoflavone or phenobarbital. In addition the tert-butylhydroquinone and tert-butylquinone concentrations in solution reached apparent steady-state levels during metabolism; the steady-state concentrations were also increased by various animal pretreatment regimens. Furthermore it was shown that the metabolism of 3-tert-butyl-4-hydroxyanisole yielded material which was covalently bound to protein. In the presence of glutathione the rates of formation of the polar metabolite(s) were enhanced 3- to 4-fold, while covalently bound products were nearly stoichiometrically decreased. The increase in the amount of polar metabolite was due to the formation of a 3-tert-butyl-4-hydroxyanisole-glutathione conjugate. 3-tert-Butyl-4-hydroxyanisole was also oxidatively metabolized by rat lung microsomes to yield the polar metabolite(s) and tert-butylhydroquinone.

The polar metabolite(s), tert-butylquinone, and tert-butylhydroquinone were also shown to be formed in isolated hepatocyte suspensions. They could be found as either the free hydroquinone, the sulfate conjugate, the glucuronide conjugate, and polar metabolites, presumedly the 3-tert-butyl-4-hydroxyanisole-glutathione conjugate. The total tert-butylhydroquinone concentration attained a steady-state level in a manner similar to that seen with the microsomal suspensions. In addition 3-tert-butyl-4-hydroxyanisole itself formed sulfate and glucuronide conjugates, the glucuronide being the major product.

¹ NIH trainee; supported in part by USPHS Grant T32 GM 07062.

² Supported in part by USPHS Grants E5 00267 and ES 01590.

³ Supported in part by USPHS Grant CA 32511; to whom requests for reprints should be addressed.

Received 7/16/84. Revised 7/15/85. Accepted 7/23/85.